These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21267453)

  • 1. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
    Rajoria S; Suriano R; George A; Shanmugam A; Schantz SP; Geliebter J; Tiwari RK
    PLoS One; 2011 Jan; 6(1):e15879. PubMed ID: 21267453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
    Kim EJ; Shin M; Park H; Hong JE; Shin HK; Kim J; Kwon DY; Park JH
    J Nutr; 2009 Dec; 139(12):2373-9. PubMed ID: 19864400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,3'-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway.
    Kim BG; Kim JW; Kim SM; Go RE; Hwang KA; Choi KC
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.
    Rajoria S; Suriano R; Wilson YL; Schantz SP; Moscatello A; Geliebter J; Tiwari RK
    Oncol Rep; 2011 Feb; 25(2):491-7. PubMed ID: 21152869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic phenotype is regulated by estrogen in thyroid cells.
    Rajoria S; Suriano R; Shanmugam A; Wilson YL; Schantz SP; Geliebter J; Tiwari RK
    Thyroid; 2010 Jan; 20(1):33-41. PubMed ID: 20067378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular target based combinational therapeutic approaches in thyroid cancer.
    Rajoria S; Suriano R; George AL; Kamat A; Schantz SP; Geliebter J; Tiwari RK
    J Transl Med; 2012 May; 10():81. PubMed ID: 22548798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway.
    Du H; Zhang X; Zeng Y; Huang X; Chen H; Wang S; Wu J; Li Q; Zhu W; Li H; Liu T; Yu Q; Wu Y; Jie L
    Front Immunol; 2019; 10():1620. PubMed ID: 31396207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.
    Tadi K; Chang Y; Ashok BT; Chen Y; Moscatello A; Schaefer SD; Schantz SP; Policastro AJ; Geliebter J; Tiwari RK
    Biochem Biophys Res Commun; 2005 Nov; 337(3):1019-25. PubMed ID: 16219298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.
    Rajoria S; Suriano R; Parmar PS; Wilson YL; Megwalu U; Moscatello A; Bradlow HL; Sepkovic DW; Geliebter J; Schantz SP; Tiwari RK
    Thyroid; 2011 Mar; 21(3):299-304. PubMed ID: 21254914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
    Ahmad A; Kong D; Sarkar SH; Wang Z; Banerjee S; Sarkar FH
    J Cell Biochem; 2009 Jun; 107(3):516-27. PubMed ID: 19330806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
    Lee GA; Hwang KA; Choi KC
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines.
    Mulvey L; Chandrasekaran A; Liu K; Lombardi S; Wang XP; Auborn KJ; Goodwin L
    Mol Med; 2007; 13(1-2):69-78. PubMed ID: 17515958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An active product of cruciferous vegetables, 3,3'-diindolylmethane, inhibits invasive properties of extravillous cytotrophoblastic cells.
    Ribaux P; Irion O; Cohen M
    Neuro Endocrinol Lett; 2012; 33(2):133-7. PubMed ID: 22592193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.
    Riby JE; Chang GH; Firestone GL; Bjeldanes LF
    Biochem Pharmacol; 2000 Jul; 60(2):167-77. PubMed ID: 10825461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
    Leong H; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2001 Nov; 22(11):1809-17. PubMed ID: 11698343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
    Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
    World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways.
    Leong H; Riby JE; Firestone GL; Bjeldanes LF
    Mol Endocrinol; 2004 Feb; 18(2):291-302. PubMed ID: 14645498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.